.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents and 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Julphar
Mallinckrodt
Novartis
Harvard Business School
Argus Health
Cipla
Fish and Richardson
Chinese Patent Office

Generated: June 24, 2017

DrugPatentWatch Database Preview

KIONEX Drug Profile

« Back to Dashboard

What is the patent landscape for Kionex, and what generic Kionex alternatives are available?

Kionex is a drug marketed by Paddock Llc and is included in two NDAs.

The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

Summary for Tradename: KIONEX

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KIONEX at DailyMed

Pharmacology for Tradename: KIONEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
KIONEX
sodium polystyrene sulfonate
SUSPENSION;ORAL, RECTAL040028-001Sep 17, 2007AARXNoNo► Subscribe► Subscribe
Paddock Llc
KIONEX
sodium polystyrene sulfonate
POWDER;ORAL, RECTAL040029-001Feb 6, 1998AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Covington
Healthtrust
Medtronic
QuintilesIMS
Boehringer Ingelheim
Cerilliant
Accenture
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot